Here are relevant reports on : continuous-glucose-monitoring-market
-
Blood Glucose Monitoring Devices Market by Product [Blood Glucose Meters, Continuous Glucose Monitoring Systems (Sensors, Transmitter), Glucose Monitoring Strips, Lancets], Application (Hospitals, Diagnostics, Home Settings) - Global Forecasts to 2019
The global blood glucose monitoring devices market is expected to grow at a significantly high rate in the next five years. Global rise in the prevalence and incidence of diabetes and increasing adoption of continuous glucose monitoring (CGM) systems are the key factors propelling the growth of this market. In addition, continuous technological advancements in blood glucose monitoring devices and rapid growth in aging population are further stimulating the demand for blood glucose monitoring devices. However, inadequate reimbursement and high cost associated with the application of CGM systems and product recalls are some of the key factors hampering the growth of this market.
- Published: July 2026
- Price: $ 4950
- TOC Available:
-
North America Blood Glucose Monitoring Devices Market by Product Type (Self-monitoring, Professional Point of Care), Application (Diabetes Management, Health & Wellness Monitoring), Test Site, End User (Self/Homecare) - Forecast to 2030
The North America Blood Glucose Monitoring Devices market, valued at USD 6.02 billion in 2024, stood at USD 6.52 billion in 2025 and is projected to advance at a resilient CAGR of 8.8% from 2025 to 2030, culminating in a forecasted valuation of USD 9.93 billion by the end of the period. The North America blood glucose monitoring devices market is experiencing steady growth, driven by several key factors. Rising diabetes prevalence, fueled by aging populations, urbanization, and lifestyle changes, is increasing demand for effective self-monitoring solutions.
- Published: June 2026
- Price: $ 4950
- TOC Available:
-
Mercury Analyzer Market by Type (Cold Vapor Atomic Absorption and Cold Vapor Atomic Fluorescence), Monitoring Type (Continuous and Lab), End-Use Industry (Environmental Monitoring, Food Industry) and Region - Global Forecast to 2029
The mercury analyzer market is expected to grow from USD 310 million in 2024 to USD 426 million by 2029, at a compound annual growth rate (CAGR) of 6.6% during the forecast period.The key players Teledyne Leeman Labs (US), Tekran Instruments Corporation (Canada), Thermo Fisher Scientific Inc. (US), PerkinElmer Inc. (US), Milestone Srl (US), Analytik Jena GmbH+Co. KG (Germany), Nippon Instruments Corporation (Japan), Hitachi High-Tech Corporation (Japan), Lumex Instruments (Canada), ENVEA (France).
- Published: May 2024
- Price: $ 4950
- TOC Available:
-
In Vitro Diagnostics Market by Product & Service (Kits, Instruments), Technology (Immunoassay, Hematology, Glucose Monitoring), Specimen (Blood), Site of Testing, Application (Endocrinology, Cardiology, Infectious Diseases) & Region- Global Forecast to 2030
The global in vitro diagnostics market, valued at USD 101.05billion in 2024, stood at USD 109.06 billion in 2025 and is projected to advance at a resilient CAGR of 7.6% from 2025 to 2030, culminating in a forecasted valuation of USD 157.63 billion by the end of the period. Market growth is primarily fueled by the rising prevalence of chronic and infectious diseases, increasing demand for rapid and accurate diagnostic solutions, and the growing shift toward personalized medicine.
- Published: May 2025
- Price: $ 4950
- TOC Available:
-
Europe In Vitro Diagnostics Market by Product & Service (Kits, Instruments), Technology (Immunoassay, Hematology, Glucose Monitoring), Specimen (Blood), Site of Testing, Application (Endocrinology, Cardiology, Infectious Diseases) - Forecast to 2031
The Europe in vitro diagnostics (IVD) market, valued at USD 31.43 billion in 2025, stood at USD 33.83 billion in 2026 and is projected to advance at a resilient CAGR of 7.9% from 2026 to 2031, culminating in a forecasted valuation of USD 49.49 billion by the end of the period. Market growth is driven by rising diagnostic test volumes across national healthcare systems, broader adoption of population-based screening programs, and increasing emphasis on standardized disease monitoring.
- Published: June 2026
- Price: $ 4950
- TOC Available:
-
Medical Wearables Market by Device (Vital Signs Monitoring, Blood Pressure Monitor, Glucose Monitor, ECG Monitor, Pulse Oximeter), Product (Smartwatch, Patches, Wristbands), End User (Hospitals, Nursing Homes, Ambulatory) & Region - Global Forecast to 2025
The global medical wearables market in terms of revenue was estimated to be worth $7.4 billion in 2020 and is poised to reach $19.5 billion by 2025, growing at a CAGR of 21.4% from 2020 to 2025. The new research study consists of an industry trend analysis of the market. The new research study consists of industry trends, pricing analysis, patent analysis, conference and webinar materials, key stakeholders, and buying behaviour in the market.
- Published: May 2020
- Price: $ 4950
- TOC Available:
-
US In Vitro Diagnostics Market by Product & Service (Kits, Instruments), Technology (Immunoassay, Hematology, Glucose Monitoring), Specimen (Blood), Site of Testing, Application (Endocrinology, Cardiology, Infectious Diseases) - Forecast to 2031
US In Vitro Diagnostics market, valued at USD 37.43 billion in 2025, stood at USD 40.15 billion in 2026 and is projected to advance at a resilient CAGR of 7.3% from 2025 to 2031, culminating in a forecasted valuation of USD 57.18 billion by the end of the period. This growth is primarily driven by the rising prevalence of chronic and infectious diseases, the increasing demand for early and accurate diagnostic testing, the widespread adoption of advanced molecular diagnostic technologies, the growth in point-of-care testing, and continuous innovations in diagnostic instruments and assays.
- Published: June 2026
- Price: $ 4950
- TOC Available:
-
Remote Patient Monitoring (RPM) Market by Offering [Software, Device (Wearable, Implants, Handheld)], Function (Cardiac, Glucose, Multiparameter), Application (Diabetes, Cardio, Neuro), End User (Hospital, ASC, Pharma & Biotech) - Global Forecast to 2031
The global remote patient monitoring market is projected to reach USD 66.33 billion by 2031, growing at a CAGR of 12.8% during the forecast period (2026–2031). The report covers key segments, regional analysis, and competitive landscape across the market ecosystem.
- Published: May 2026
- Price: $ 4950
- TOC Available:
-
Asia Pacific In Vitro Diagnostics Market by Product & Service (Kits, Instruments), Technology (Immunoassay, Hematology, Glucose Monitoring), Specimen (Blood), Site of Testing, Application (Endocrinology, Cardiology, Infectious Diseases) - Forecast to 2031
The Asia Pacific in vitro diagnostics market is valued at an estimated USD 29.27 billion in 2026 and is projected to reach USD 45.11 billion by 2031 at a CAGR of 9.0% during the forecast period. The Key Players F. Hoffmann-La Roche Ltd (Switzerland), Abbott (US), Danaher (US), Sysmex Corporation (Japan), Shenzhen Mindray Bio-Medical Electronics Co., (China)., Siemens Healthineers AG (Germany), bioMérieux (France), Illumina, Inc. (US), Becton, Dickinson and Company (US), and QuidelOrtho Corporation (US).
- Published: June 2026
- Price: $ 4950
- TOC Available:
-
Latin America In Vitro Diagnostics Market by Product & Service (Kits, Instruments), Technology (Immunoassay, Hematology, Glucose Monitoring), Specimen (Blood), Site of Testing, Application (Endocrinology, Cardiology, Infectious Disease) - Forecast to 2031
The Latin America in vitro diagnostics (IVD) market, valued at USD 5.48 billion in 2025, stood at USD 5.87 billion in 2026 and is projected to advance at a resilient CAGR of 6.7% from 2026 to 2031, culminating in a forecasted valuation of USD 8.13 billion by the end of the period. The increasing demand for diagnostic services, along with the growing need for routine and specialized testing, is driving the market. Investments in lab infrastructure, combined with the adoption of automated and standardized diagnostic procedures, contribute to increasing test volumes in both the public and private healthcare sectors.
- Published: June 2026
- Price: $ 4950
- TOC Available:
Records 1 to 10 of 50
